Company news

Lexeo Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Lexeo Therapeutics Strengthens Clinical Development Leadership with New Executive Appointments

February 4, 2024

Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)

December 17, 2023

Lexeo Therapeutics Reports Third Quarter 2023 Financial Results and Operational Highlights

December 10, 2023

← Newer news releases

Decks

The 5 newest of 18 decks. Every deck is listed under its year.